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Background. The feasibility and accuracy of immunohistochemistry (IHC) on frozen sections, when assessing sentinel node (SN)
status intraoperatively in breast cancer, is a matter of continuing discussion. In this study, we compared a center using IHC
on frozen section with a center not using this method with focus on intraoperative diagnostic values. Material and Methods.
Results from 336 patients from the centre using IHC intraoperatively were compared with 343 patients from the center not
using IHC on frozen section. Final evaluation on paraﬃn sections with haematoxylin-eosin (HE) staining supplemented with
cytokeratinstainingwasusedasgoldstandard.Results.SigniﬁcantlymoreSNwithisolatedtumorcells(ITCs)andmicrometastases
(MICs) were found intraoperatively when using IHC on frozen sections. There was no signiﬁcant diﬀerence in the number of
macrometastases (MACs) found intraoperatively. IHC increased the sensitivity, the negative predictive value, and the accuracy of
the intraoperative evaluation of SN without decreasing the speciﬁcity and positive predictive value of SN evaluation. Conclusions.
I H Co nf r o z e ns e c t i o nl e a d st ot h ed e t e c t i o no fm o r eI T Ca n dM I Cintraoperatively. As axillary lymph node dissection (ALND)
is performed routinely in some countries when ITC and MIC are found in the SN, IHC on frozen section provides valuable
information that can lead to fewer secondary ALNDs.
1.Introduction
Axillary lymph node status is the most important prognostic
factor in breast cancer. Sentinel node biopsy (SNB) is
regarded as an accurate method for assessing axillary lymph
node status in patients with early breast cancer [1, 2]. The
morecomprehensiveanalysisofSNshasresultedinincreased
detection of metastatic and micrometastatic disease both
by haematoxylin-eosin (HE) staining and by immunohis-
tochemistry (IHC) [3–5]. Only in case of involvement of
the SN are patients oﬀered an axillary lymph node dissec-
tion (ALND). If SN involvement is found intraoperatively,
ALND can be done immediately at the same operation and
patients are spared a two-stage procedure. However, there
is no universal agreement on the optimal method for the
intraoperative examination of the SNs. A higher number of
SN involvement diagnosed correctly intraoperatively would
increase the number of patients having ALND in the same
operation and fewer would go through a second axillary
operation because of late diagnosis of SN involvement.
In 2003, the American Joint Committee on Cancer
(AJCC)revisedthebreastcancerstagingsystem(6thedition)
with particular attention to the distinction of micrometas-
tases (MICs) and isolated tumor cells (ITCs) [6]. This revi-
sion classiﬁes ITC (≤0.2mm) as node-negative (pN0(i+)).
ITCs are deﬁned as clusters of single tumor cells which are
usually detected only by IHC or molecular methods but
can be veriﬁed on HE-stained sections. Cases with MIC
(>0.2mm to 2mm) are now classiﬁed as node-positive
(pN1mi). These recent changes to the AJCC staging for2 Pathology Research International
Table 1: Comparison of evaluations on frozen sections and paraﬃn sections of 335 patients with sentinel node biopsies with IHC on frozen
sections (group 1).
Final evaluation on paraﬃns e c t i o n s
Evaluation on frozen sections
No metastasis Metastasis Total
No metastasis 217 (100%) 0 (0%) 217
ITC 3 (23%) 10 (77%) 13
MIC 7 (28%) 18 (72%) 25
MAC 5 (6%) 75 (94%) 80
Total 232 (69%) 103 (31%) 335
Table 2: Comparison of evaluations on frozen sections and paraﬃn section of 336 patients with sentinel node biopsies without IHC on
frozen sections (group 2).
Final evaluation on paraﬃns e c t i o n s
Evaluation on frozen sections
No metastasis Metastasis Total
No metastasis 220 (100%) 0 (0%) 220
ITC 11 (92%) 1 (8%) 12
MIC 29 (83%) 6 (17%) 35
MAC 6 (9%) 63 (91%) 69
Total 266 (79%) 70 (21%) 336
lymph nodes containing ITC and MIC have standardized the
classiﬁcation of these metastases. In Denmark, ALND is at
the moment routinely performed on patients with ITCs and
MICs as well as macrometastases (MACs). Internationally,
however, there are diverging opinions as to the necessity of
ALND for ITC and MIC and this is not standard procedure
in all countries.
The aim of this study was to investigate the feasibility
and accuracy of IHC staining in detecting axillary node
involvement intraoperatively. We determined the concor-
dance between intraoperative frozen section evaluations
with and without IHC and ﬁnal standard evaluation on
HE-stained paraﬃn sections supplemented with cytokeratin
staining with regard to the detection of MAC, MIC, and ITC.
2.MaterialandMethods
SNs from 336 breast cancer patients operated at Herlev
Hospital during the period January 1, 2009 to July 14, 2009
were evaluated intraoperatively with anticytokeratin IHC
on frozen sections (group 1). Sentinel nodes removed were
sent for frozen section. Lymph nodes measuring more than
4mm in diameter were bisected, and very large lymph nodes
were sliced at 2-3mm intervals. Frozen step sections were
done at two levels 200 microns apart with 2 HE and one
section with anticytokeratin AE1/AE3 IHC (DAKO, ready
to use). This is a quick method with a turnaround time of
20 minutes resulting in only minor prolongation of surgery
[7]. Intraoperative analysis was limited to positive (any
involvement) versus negative, and no attempt to subclassify
positives into MAC/MIC/ITC was done.
343 patients operated at Rigshospitalet during the same
period were evaluated intraoperatively using the same
method as described for group 1, but without cytokeratin
staining (group 2). In both groups, the sentinel nodes were
formalin ﬁxed and paraﬃn sections (2 levels were cut, 500
microns apart) were done with HE staining supplemented
with cytokeratin staining.
The nodal involvement was classiﬁed according to the
6th edition of the AJCC manual. Consistent with standard
clinical practice, the pathology is reported on a patient basis,
based on the most extensive disease found in any of the SNs.
Patients listed on the pathology report as having less than
10 tumor cells identiﬁed (according to DBCG guidelines) or
nodal involvement ≤0.2mm on HE or IHC were classiﬁed as
ITC.Ifthepathologyreportdidnotspecifythesizeordidnot
speciﬁcallyreportITCs,thepatientwasclassiﬁedintheMAC
group. The total number of SNs removed and the number
of sentinel nodes with MAC, MIC, ITC, and no involvement
were registered for each individual patient both with regard
to the frozen section evaluation and with regard to the ﬁnal
evaluation.
Comparisonsofresultsbetweengroup1and2weremade
by the chi-square test except in cases where the number of
observations was less than 40, in which case Fisher’s exact
test was used.
3. Results
SN status for group 1 is shown in Table 1 and, for group 2,
in Table 2.I ng r o u p1 ,o n ep a t i e n tw a se x c l u d e da sI H Co n
frozen section failed. In group 2, 7 patients were excluded
due to lack of a Danish registration number and therefore no
possibility of follow-up.
The total number of patients with nodal involvement
(MAC, MIC, and ITC) at the ﬁnal evaluation on paraﬃn
sections was 118 out of 335 in group 1 and 116 out of 336
in group 2. There was no signiﬁcant diﬀerence between thePathology Research International 3
Table 3: Diagnostic values for frozen section with and without IHC.
IHC No IHC
Sensitivity 87.3% (103/118) 60.3% (70/116)
Speciﬁcity 100% (217/217) 100% (220/220)
Positive predictive value 100% (103/103) 100% (70/70)
Negative predictive value 93.5% (217/232) 82.6% (220/266)
Accuracy 95.5% (320/335) 86.0% (290/336)
Table 4: Diagnostic values for MIC/ITC versus MAC.
IHC No IHC
MIC/ITC MAC MIC/ITC MAC
Sensitivity 73.7% (28/38) 93.8% (75/80) 14.9% (7/47) 91.3% (63/69)
Speciﬁcity 100% (217/217) 100% (217/217) 100% (220/220) 100% (220/220)
Positive predictive value 100% (28/28) 100% (75/75) 100% (7/7) 100% (63/63)
Negative predictive value 95.6% (217/227) 97.8% (217/222) 84.6% (220/260) 97.3% (220/226)
Accuracy 96.1% (245/255) 98.3% (292/297) 85% (227/267) 97.9% (283/289)
two groups with regard to frequency of SN involvement on
ﬁnal evaluation (P = 0.88).
In group 1, 103 out of 118 patients had nodal involve-
ment correctly diagnosed on frozen sections. This was
signiﬁcantly better than in group 2 where 70 out of 116
patients had nodal involvement correctly diagnosed on
frozen sections (P<0.02).
Diagnostic values for frozen section with and without
IHC are presented in Table 3 a n df o rM I C / I T Cv e r s u sM A C
with and without IHC in Table 4.
We found a statistically signiﬁcant diﬀerence between
the number of MIC found on frozen sections with IHC
and without IHC (P<0.005). Furthermore, we found a
statistically signiﬁcant diﬀerence between the number of ITC
f o u n do nf r o z e ns e c t i o n sw i t hI H Ca n dw i t h o u tI H C( P =
0.001).
On the contrary, the number of MAC found on frozen
sections with IHC was not signiﬁcantly diﬀerent from the
n u m b e ro fM A Cf o u n dw i t h o u tI H C( P = 0.88).
222 patients with MAC, MIC, or ITC had ALND. 12
patients did not have ALND despite having involvement in
the SN due to comorbidity or the patient’s wishes. For 8 of
these patients, the nodal involvement was not found until
ﬁnal evaluation, while, in 4 patients, involvement was found
on frozen section. These 4 patients had minimal involvement
of the SNs, that is, ITC or MIC, and didnot therefore have
ALND due to comorbidity of the patients.
4. Discussion
In the present study, we compared results from a center
using only frozen section intraoperatively with results from
a center using frozen section with IHC. We found a signiﬁ-
cantly higher number of MIC and ITC correctly diagnosed
intraoperatively when IHC was applied than without. The
number of MAC was not signiﬁcantly diﬀerent. This is in
accordance with other studies on intraoperative IHC, where
the diﬀerence in positive ﬁndings was also seen for MIC and
ITC. The ability for frozen section to diagnose MAC, how-
ever, seems to be as good as frozen section with IHC. This is
furtherunderlinedbythediagnosticvaluesshowninTable 4.
For frozen section without IHC, previous studies have
found sensitivities of 36–95.8% [8–12], accuracies of 83–
96% [8, 9, 12, 13], and negative predictive values of 81–98%
[9, 10, 14]. Corresponding values for frozen section with
IHC and IHC alone have been 83–92% (sensitivity) [13–16],
92.2–97.5% (accuracy) [11, 13, 15], and 86–95.2% (negative
predictivevalue)[13,14].Speciﬁcitiesandpositivepredictive
valuesareusuallyveryhighforbothmethods.Ourresultsfall
within the range of these previous ﬁndings.
The large divergence in results seen in other studies may
be due to diﬀerences in techniques and number of sections
both intraoperatively and at postoperative examination.
Also, many of the studies have included relatively few
patients. In contrast, our study is based on a relatively large
number of patients. We show that IHC intraoperatively can
be a valuable addition to frozen section, using a method
that is feasible in the clinic, that is, not too time consuming.
However, it must be taken into consideration that this
was a retrospective study and that the patients who had
frozen sections without IHC came from a diﬀerent, although
similar, center than the ones who had frozen sections with
IHC. Hence, it is possible that diﬀerences in technique
between the two centers may have inﬂuenced the results.
A correct diagnosis of SN status intraoperatively can
reduce the number of patients oﬀered ALND as a second
operation. When intraoperative IHC was ﬁrst introduced
at our hospital, a study was undertaken to evaluate the
economic implications of a slightly prolonged ﬁrst surgery
compared to fewer patients having to go through a later
ALND. The cost analysis at that time showed a cost
saving of approximately 40% [7]. Another study has shown
an increased length of hospitalization and operating time
for patients who had late ALND [17]. Few studies have4 Pathology Research International
investigated objective and subjective arm morbidity in
patients undergoing late ALND compared to those having
only one operation, and results are diverging [17–20]. Still,
immediate staging of the axilla by SNB and subsequent
ALND if necessary under the same operation must be
preferred.
8 of the 12 patients in our study who did not have ALND
despite involvement in the SN had their nodal involvement
diagnosed on ﬁnal evaluation. Patients having to undergo a
second operation for ALND may be more prone to declining
ALND to avoid a second hospitalization. However, this study
did not provide data as to why the patients declined ALND.
However, the beneﬁt of discovering ITC and MIC
intraoperatively depends on how patients with these ﬁndings
are managed further. The optimal treatment strategy for
these patients is now being discussed, and it is questioned
whether there is any prognostic advantage in performing
ALND. Recently published data showed no survival beneﬁt
from ALND in patients with limited SN metastatic breast
cancer treated with breast conservation and systemic therapy
[21]. If the future management of breast cancer with ITC
or MIC in the sentinel node does not involve ALND, there
will be no added beneﬁt from the detection of metastases
intraoperatively compared to ﬁnal evaluation.
5. Conclusion
IHC intraoperatively adds information to frozen section
evaluation. In the present study, IHC increased the sen-
sitivity, the negative predictive value, and the accuracy of
the intraoperative evaluation of SN without decreasing the
speciﬁcity and positive predictive value, of SN evaluation.
However, intraoperative IHC only increased the number of
patients diagnosed with MIC and ITC, whereas the number
of patients with MAC was the same in both groups.
The present study indicates that frozen section with IHC
is a clinically useful method as it enables the detection
of more nodal involvement intraoperatively, thus allowing
ALND to be performed immediately during the same oper-
ation in a larger proportion of patients. Hence, a number of
patients are spared a second operation. Evidently, however,
this method is only relevant as long as patients with ITC and
MIC are routinely treated with subsequent ANLD, as is the
case in Denmark.
Recently, molecular assays (one-step nucleic acid ampli-
ﬁcation (OSNA), quantitative reverse transcription-polym-
erase chain reaction (QRT-PCR)) have been introduced to
the intraoperative evaluation of SNs. These procedures yield
diagnostic values comparable to those found in our study
for IHC on frozen sections [22, 23]. IHC on frozen sections,
however, does not require additional equipment and might
therefore be an aﬀordable alternative to these molecular
assays.
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